- Revenue · quarter
- 3.16B USD
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Gross profit · quarter
- 1.04B USD
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Operating income · quarter
- -2.1B USD
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Net income · quarter
- -1.44B USD
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Diluted EPS · quarter
- -6.46 USD/shares
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Operating cash flow · quarter
- 1.31B USD
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Capital expenditure · quarter
- 995.7M USD
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Free cash flow · quarter
- 309.5M USD
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Revenue · trailing 12 months
- 12.6B USD
- Jul 1, 2025 – Jun 30, 2026
- Provider TTM · observed Sep 21, 2026
- Gross profit · trailing 12 months
- 4.04B USD
- Jul 1, 2025 – Jun 30, 2026
- Provider TTM · observed Sep 21, 2026
- Operating income · trailing 12 months
- -593.1M USD
- Jul 1, 2025 – Jun 30, 2026
- Provider TTM · observed Sep 21, 2026
- Net income · trailing 12 months
- -47.3M USD
- Jul 1, 2025 – Jun 30, 2026
- Provider TTM · observed Sep 21, 2026
- Operating cash flow · trailing 12 months
- 4.57B USD
- Jul 1, 2025 – Jun 30, 2026
- Provider TTM · observed Sep 21, 2026
- Capital expenditure · trailing 12 months
- 5.02B USD
- Jul 1, 2025 – Jun 30, 2026
- Provider TTM · observed Sep 21, 2026
- Free cash flow · trailing 12 months
- 2.06B USD
- Jul 1, 2025 – Jun 30, 2026
- Provider TTM · observed Sep 21, 2026
- Total assets
- 40.45B USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Total liabilities
- 23.85B USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Shareholders’ equity
- 13.88B USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Cash and equivalents
- 980.5M USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Consolidated debt
- 18.16B USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Current assets
- 4.96B USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Current liabilities
- 4.58B USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Inventory
- 751.6M USD
- At Jun 30, 2026
- Provider observation · observed Sep 21, 2026
- Weighted average diluted shares
- 222.8M shares
- At Jun 30, 2026
- Provider quarter · observed Sep 21, 2026
- Reported shares outstanding
- 222.69M shares
- At Jun 30, 2026
- Diluted EPS · fiscal year
- -1.77 USD/shares
- Oct 1, 2024 – Sep 30, 2025
- Gross margin
- 32.06%
- Provider TTM · observed Sep 22, 2026
- Operating margin
- -4.71%
- Provider TTM · observed Sep 22, 2026
- Net margin
- -0.38%
- Provider TTM · observed Sep 22, 2026
- Current ratio
- 1.08x
- Provider TTM · observed Sep 22, 2026
- Quick ratio
- 0.92x
- Provider TTM · observed Sep 22, 2026
- Return on assets
- -0.12%
- Provider TTM · observed Sep 21, 2026
- Return on equity
- -0.32%
- Provider TTM · observed Sep 21, 2026
- Return on invested capital
- 0.08%
- Provider TTM · observed Sep 21, 2026
- Revenue growth · trailing 12 months
- +4.51%
- Jul 1, 2025 – Jun 30, 2026
- Net income growth · trailing 12 months
- -103.05%
- Jul 1, 2025 – Jun 30, 2026
- Debt to equity
- 1.31x
- Provider TTM · observed Sep 22, 2026
- Debt to assets
- 44.89%
- Provider TTM · observed Sep 22, 2026
- Interest coverage
- -2.68x
- Provider TTM · observed Sep 22, 2026